ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE000G2LIHG9
Stock Name / FundiShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF TickerSAUA(EUR) ETF Plus

Holdings detail for INCY

Stock NameIncyte Corporation
TickerINCY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45337C1027
LEI549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib
(RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update
Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY)
Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00
Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY)
Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC
Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)
Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)
Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY)
Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY)
State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY)
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY)
Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY)
Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus
Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc) INCY holdings

DateNumber of INCY Shares HeldBase Market Value of INCY SharesLocal Market Value of INCY SharesChange in INCY Shares HeldChange in INCY Base ValueCurrent Price per INCY Share HeldPrevious Price per INCY Share Held
2026-02-09 (Monday)52,423USD 5,715,680USD 5,715,680
2026-02-06 (Friday)52,483INCY holding increased by 29USD 5,688,632INCY holding increased by 303180USD 5,688,63229USD 303,180 USD 108.39 USD 102.67
2026-02-02 (Monday)52,454INCY holding increased by 100USD 5,385,452INCY holding increased by 146387USD 5,385,452100USD 146,387 USD 102.67 USD 100.07
2026-01-30 (Friday)52,354INCY holding increased by 70USD 5,239,065INCY holding decreased by -45802USD 5,239,06570USD -45,802 USD 100.07 USD 101.08
2026-01-29 (Thursday)52,284INCY holding increased by 20USD 5,284,867INCY holding decreased by -122889USD 5,284,86720USD -122,889 USD 101.08 USD 103.47
2026-01-27 (Tuesday)52,264INCY holding increased by 330USD 5,407,756INCY holding increased by 80366USD 5,407,756330USD 80,366 USD 103.47 USD 102.58
2026-01-26 (Monday)51,934INCY holding increased by 70USD 5,327,390INCY holding increased by 37781USD 5,327,39070USD 37,781 USD 102.58 USD 101.99
2026-01-23 (Friday)51,864INCY holding decreased by -60USD 5,289,609INCY holding decreased by -145276USD 5,289,609-60USD -145,276 USD 101.99 USD 104.67
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE000G2LIHG9

Show aggregate share trades of INCY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-02-06BUY29 108.390* -
2026-02-02BUY100102.86099.500 99.836USD 9,984 -
2026-01-30BUY70101.21099.280 99.473USD 6,963 -
2026-01-29BUY20101.890100.210 100.378USD 2,008 -
2026-01-27BUY330105.060102.590 102.837USD 33,936 -
2026-01-26BUY70103.420101.100 101.332USD 7,093 -
2026-01-23SELL-60104.700100.070 100.533USD -6,032 -
2026-01-21BUY40105.410101.000 101.441USD 4,058 -
2026-01-20SELL-60103.850100.000 100.385USD -6,023 -
2026-01-19SELL-18 106.210* -
2026-01-15BUY30106.740104.270 104.517USD 3,136 -
2026-01-14SELL-170107.640103.198 103.642USD -17,619 -
2026-01-12SELL-299106.940105.280 105.446USD -31,528 -
2026-01-08BUY80110.060104.690 105.227USD 8,418 -
2026-01-07BUY20112.290107.970 108.402USD 2,168 -
2026-01-05SELL-594103.00099.040 99.436USD -59,065 -
2026-01-02BUY66101.49097.940 98.295USD 6,487 -
2025-12-29BUY44100.08097.630 97.875USD 4,306 -
2025-12-23BUY209101.710100.040 100.207USD 20,943 -
2025-12-22BUY10102.51098.990 99.342USD 993 -
2025-12-19BUY130103.45097.360 97.969USD 12,736 -
2025-12-18SELL-18098.34097.010 97.143USD -17,486 -
2025-12-17BUY18098.90097.090 97.271USD 17,509 -
2025-12-16BUY19998.69096.400 96.629USD 19,229 -
2025-12-12BUY22296.00093.540 93.786USD 20,820 -
2025-12-11BUY3096.87594.390 94.638USD 2,839 -
2025-12-10BUY4096.88094.280 94.540USD 3,782 -
2025-12-09BUY5097.98094.660 94.992USD 4,750 -
2025-12-08BUY20100.43094.380 94.985USD 1,900 -
2025-12-05SELL-10103.68098.360 98.892USD -989 -
2025-12-04SELL-108102.47099.690 99.968USD -10,797 -
2025-12-03BUY60102.622100.900 101.072USD 6,064 -
2025-12-02SELL-90103.540100.550 100.849USD -9,076 -
2025-12-01BUY970103.890101.470 101.712USD 98,660 -
2025-11-28BUY98106.990103.850 104.164USD 10,208 -
2025-11-26SELL-30107.000105.085 105.276USD -3,158 -
2025-11-26SELL-30107.000105.085 105.276USD -3,158 -
2025-11-25BUY170107.605105.160 105.405USD 17,919 -
2025-11-24BUY320106.670102.503 102.920USD 32,934 -
2025-11-21BUY55103.200101.400 101.580USD 5,587 -
2025-11-20BUY11103.225101.080 101.295USD 1,114 -
2025-11-19BUY63104.660100.300 100.736USD 6,346 -
2025-11-18BUY198107.265103.790 104.137USD 20,619 -
2025-11-17BUY80105.970103.830 104.044USD 8,324 -
2025-11-14SELL-60106.920103.770 104.085USD -6,245 -
2025-11-12BUY360109.275106.810 107.056USD 38,540 -
2025-11-10BUY193108.810104.070 104.544USD 20,177 -
2025-11-07SELL-12106.400103.810 104.069USD -1,249 -
2025-11-06SELL-40106.430103.075 103.410USD -4,136 -
2025-11-05BUY130106.470101.500 101.997USD 13,260 -
2025-11-04BUY160103.860100.020 100.404USD 16,065 -
2025-11-03SELL-88101.79091.160 92.223USD -8,116 -
2025-10-30BUY55094.62091.190 91.533USD 50,343 -
2025-10-29BUY55090.18094.420 93.996USD 51,698 -
2025-10-28BUY5591.65093.980 93.747USD 5,156 -
2025-10-27BUY3393.08093.170 93.161USD 3,074 -
2025-10-24BUY2291.28092.080 92.000USD 2,024 -
2025-10-21BUY3387.30087.480 87.462USD 2,886 -
2025-10-20BUY12186.17087.950 87.772USD 10,620 -
2025-10-16BUY11087.31092.860 92.305USD 10,154 -
2025-10-15BUY13088.15088.490 88.456USD 11,499 -
2025-10-03BUY4086.85086.980 86.967USD 3,479 -
2025-10-02BUY8086.28088.660 88.422USD 7,074 -
2025-10-01BUY12486.70087.240 87.186USD 10,811 -
2025-09-30BUY73084.81085.310 85.260USD 62,240 -
2025-09-29BUY19083.89084.410 84.358USD 16,028 -
2025-09-26BUY43082.70082.950 82.925USD 35,658 -
2025-09-25BUY3081.66084.450 84.171USD 2,525 -
2025-09-24BUY57784.16084.820 84.754USD 48,903 -
2025-09-18BUY12086.00086.070 86.063USD 10,328 -
2025-09-17BUY15084.80085.980 85.862USD 12,879 -
2025-09-16BUY24083.90084.580 84.512USD 20,283 -
2025-09-11SELL-1086.17087.100 87.007USD -870 -
2025-09-10BUY64086.25086.940 86.871USD 55,597 -
2025-09-09BUY4485.60087.350 87.175USD 3,836 -
2025-08-06BUY22677.65079.430 79.252USD 17,911 -
2025-07-31BUY6574.89077.460 77.203USD 5,018 -
2025-07-29BUY26077.38077.870 77.821USD 20,233 -
2025-07-28BUY4870.16070.930 70.853USD 3,401 -
2025-07-25BUY7870.20070.820 70.758USD 5,519 -
2025-07-24BUY3870.49071.290 71.210USD 2,706 -
2025-07-23BUY9170.69070.830 70.816USD 6,444 -
2025-07-22BUY5268.90069.120 69.098USD 3,593 -
2025-07-18BUY8867.86069.430 69.273USD 6,096 -
2025-07-17BUY7868.94069.650 69.579USD 5,427 -
2025-07-11BUY10468.59069.970 69.832USD 7,263 -
2025-07-10BUY11770.34070.620 70.592USD 8,259 -
2025-07-09BUY11768.72069.300 69.242USD 8,101 -
2025-07-07SELL-7867.27068.250 68.152USD -5,316 -
2025-07-02SELL-32568.17069.100 69.007USD -22,427 -
2025-06-27BUY3968.37071.120 70.845USD 2,763 -
2025-06-26BUY3970.81071.500 71.431USD 2,786 -
2025-06-24SELL-18269.01069.540 69.487USD -12,647 -
2025-06-18BUY10468.27069.470 69.350USD 7,212 -
2025-06-17BUY3968.81070.890 70.682USD 2,757 -
2025-06-16SELL-5371.22071.290 71.283USD -3,778 -
2025-06-13BUY11467.75068.960 68.839USD 7,848 -
2025-06-12SELL-6569.22069.540 69.508USD -4,518 -
2025-06-11BUY14368.85070.360 70.209USD 10,040 -
2025-06-06BUY3968.77068.980 68.959USD 2,689 -
2025-06-05BUY18267.24067.870 67.807USD 12,341 -
2025-06-04BUY2467.42068.450 68.347USD 1,640 -
2025-06-03SELL-1267.11070.970 70.584USD -847 -
2025-05-30SELL-1,46465.06065.770 65.699USD -96,183 -
2025-05-29BUY3666.04066.260 66.238USD 2,385 -
2025-05-27BUY20465.35065.800 65.755USD 13,414 -
2025-05-23BUY18064.25064.570 64.538USD 11,617 -
2025-05-22BUY8464.51065.330 65.248USD 5,481 -
2025-05-19BUY7263.81064.300 64.251USD 4,626 -
2025-05-16BUY3663.31063.480 63.463USD 2,285 -
2025-05-15SELL-2462.76062.990 62.967USD -1,511 -
2025-05-14BUY1261.16062.500 62.366USD 748 -
2025-05-13BUY2460.81061.150 61.116USD 1,467 -
2025-05-08BUY2459.73059.990 59.964USD 1,439 -
2025-05-07BUY3659.55060.070 60.018USD 2,161 -
2025-05-02BUY1,33262.53062.870 62.836USD 83,698 -
2025-04-30BUY42062.66062.870 62.849USD 26,397 -
2025-04-29BUY10860.43060.720 60.691USD 6,555 -
2025-04-28BUY8459.52059.600 59.592USD 5,006 -
2025-04-25BUY21659.16059.210 59.205USD 12,788 -
2025-04-24SELL-25258.97059.050 59.042USD -14,879 -
2025-04-23BUY22858.00059.010 58.909USD 13,431 -
2025-04-22BUY9657.38058.040 57.974USD 5,566 -
2025-04-17BUY13258.21058.690 58.642USD 7,741 -
2025-04-15BUY12058.46059.950 59.801USD 7,176 -
2025-04-11BUY20856.87057.070 57.050USD 11,866 -
2025-04-09BUY7258.86059.370 59.319USD 4,271 -
2025-04-08BUY43256.97061.470 61.020USD 26,361 -
2025-04-07BUY14460.29061.060 60.983USD 8,782 -
2025-04-04SELL-19260.58063.570 63.271USD -12,148 -
2025-04-02BUY1,63262.33062.530 62.510USD 102,016 -
2025-04-01BUY1260.91062.000 61.891USD 743 -
2025-03-31BUY8460.55060.810 60.784USD 5,106 -
2025-03-28BUY4860.60060.970 60.933USD 2,925 -
2025-03-27BUY2460.68061.640 61.544USD 1,477 -
2025-03-26BUY1261.26062.880 62.718USD 753 -
2025-03-25BUY13262.08063.270 63.151USD 8,336 -
2025-03-24BUY15662.78063.310 63.257USD 9,868 -
2025-03-21SELL-4861.92062.330 62.289USD -2,990 -
2025-03-20BUY19260.58061.750 61.633USD 11,834 -
2025-03-19BUY3660.34061.150 61.069USD 2,198 -
2025-03-18BUY43260.00061.030 60.927USD 26,320 -
2025-03-17BUY8462.01063.450 63.306USD 5,318 -
2025-03-14BUY62467.86068.120 68.094USD 42,491 -
2025-03-13BUY12067.71068.970 68.844USD 8,261 -
2025-03-12SELL-60067.73068.230 68.180USD -40,908 -
2025-03-11SELL-44468.07071.650 71.292USD -31,654 -
2025-03-10BUY13271.13071.890 71.814USD 9,479 -
2025-03-07BUY2470.79072.810 72.608USD 1,743 -
2025-03-05BUY18069.81069.970 69.954USD 12,592 -
2025-03-04BUY20469.68070.000 69.968USD 14,273 -
2025-03-03BUY38470.26073.450 73.131USD 28,082 -
2025-02-28BUY31273.50073.630 73.617USD 22,969 -
2025-02-27SELL-6073.18074.600 74.458USD -4,467 -
2025-02-25BUY44474.40076.240 76.056USD 33,769 -
2025-02-21BUY4872.11072.970 72.884USD 3,498 -
2025-02-18SELL-10871.27071.680 71.639USD -7,737 -
2025-02-14SELL-73270.42071.800 71.662USD -52,457 -
2025-02-13BUY1270.01072.690 72.422USD 869 -
2025-02-12BUY11869.05069.100 69.095USD 8,153 -
2025-02-07SELL-1774.13076.960 76.677USD -1,304 -
2025-02-06BUY22874.95075.490 75.436USD 17,199 -
2025-02-05BUY6075.26075.740 75.692USD 4,542 -
2025-02-04BUY7274.12074.920 74.840USD 5,388 -
2025-02-03BUY7273.74075.000 74.874USD 5,391 -
2025-01-31BUY13274.16075.180 75.078USD 9,910 -
2025-01-29SELL-1273.72074.110 74.071USD -889 -
2025-01-28SELL-10873.15073.990 73.906USD -7,982 -
2025-01-27SELL-19272.64073.430 73.351USD -14,083 -
2025-01-24BUY14472.59073.680 73.571USD 10,594 -
2025-01-23BUY2472.53072.880 72.845USD 1,748 -
2025-01-22BUY19772.41073.550 73.436USD 14,467 -
2025-01-21BUY14473.47073.980 73.929USD 10,646 -
2025-01-16BUY22172.47072.980 72.929USD 16,117 -
2025-01-14BUY9671.93072.930 72.830USD 6,992 -
2025-01-10BUY28870.54072.600 72.394USD 20,849 -
2024-12-30BUY3668.42068.870 68.825USD 2,478 -
2024-12-27BUY4869.23069.900 69.833USD 3,352 -
2024-12-23BUY36069.84070.190 70.155USD 25,256 -
2024-12-20BUY9668.84069.110 69.083USD 6,632 -
2024-12-19BUY1267.06068.640 68.482USD 822 -
2024-12-18BUY9667.55069.630 69.422USD 6,665 -
2024-12-17BUY2469.40069.740 69.706USD 1,673 -
2024-12-16BUY12069.80070.880 70.772USD 8,493 -
2024-12-13BUY8668.55070.790 70.566USD 6,069 -
2024-12-10BUY60072.48073.100 73.038USD 43,823 -
2024-12-09BUY7272.11075.980 75.593USD 5,443 -
2024-12-06SELL-18075.92076.460 76.406USD -13,753 -
2024-12-05SELL-1274.92075.370 75.325USD -904 -
2024-12-03BUY6072.03072.960 72.867USD 4,372 -
2024-11-27SELL-7275.45076.140 76.071USD -5,477 -
2024-11-26BUY25274.80074.950 74.935USD 18,884 -
2024-11-25BUY3373.52073.870 73.835USD 2,437 -
2024-11-22SELL-2471.72072.000 71.972USD -1,727 -
2024-11-21SELL-6070.39071.400 71.299USD -4,278 -
2024-11-20SELL-2471.05071.680 71.617USD -1,719 -
2024-11-19BUY1270.56074.100 73.746USD 885 -
2024-11-18BUY10876.97077.010 77.006USD 8,317 -
2024-11-11BUY3681.53083.540 83.339USD 3,000 -
2024-11-07BUY3282.34082.970 82.907USD 2,653 -
2024-11-06BUY28880.95082.190 82.066USD 23,635 -
2024-11-05BUY6077.28077.370 77.361USD 4,642 -
2024-11-04BUY2275.75076.570 76.488USD 1,683 -
2024-11-01BUY3376.13076.330 76.310USD 2,518 -
2024-10-30SELL-7273.93074.600 74.533USD -5,366 -
2024-10-29SELL-21673.60074.070 74.023USD -15,989 -
2024-10-28SELL-8465.69065.880 65.861USD -5,532 -
2024-10-21SELL-1265.27066.550 66.422USD -797 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19321,923395451,11071.4%
2025-09-18244,9471,423469,74752.1%
2025-09-17277,858779546,95350.8%
2025-09-16359,781946576,37962.4%
2025-09-15347,4534582,22859.7%
2025-09-12353,0400631,53455.9%
2025-09-11448,7333,894739,70160.7%
2025-09-10490,727248671,93273.0%
2025-09-09515,3951,822682,79175.5%
2025-09-08308,184119479,82864.2%
2025-09-05256,7192,505512,04950.1%
2025-09-04422,6241,507834,71750.6%
2025-09-03381,6797,777624,92261.1%
2025-09-02547,12015,396816,26767.0%
2025-08-29148,294262304,42748.7%
2025-08-28164,0080347,48047.2%
2025-08-27248,926453513,40148.5%
2025-08-26365,1306709,32051.5%
2025-08-25478,1301,306642,31974.4%
2025-08-22344,3522,023596,30157.7%
2025-08-21198,7294,881335,30159.3%
2025-08-20351,6993,977555,34563.3%
2025-08-19343,1103,146574,32859.7%
2025-08-18366,1244,996653,10356.1%
2025-08-15480,8858,035625,79776.8%
2025-08-14593,55436,654806,06873.6%
2025-08-13845,18198,1601,257,50367.2%
2025-08-12462,89642,208678,68968.2%
2025-08-11385,211696595,89264.6%
2025-08-08248,925738426,18758.4%
2025-08-07268,864929420,48663.9%
2025-08-06554,642891731,48475.8%
2025-08-05361,6872,092623,87958.0%
2025-08-04338,0051,464519,15065.1%
2025-08-01414,814828572,87972.4%
2025-07-31570,8456,148777,41773.4%
2025-07-30471,30314,166881,19453.5%
2025-07-29966,64010,5811,593,70160.7%
2025-07-28382,23662625,51061.1%
2025-07-25216,96749422,99051.3%
2025-07-24348,27623528,51765.9%
2025-07-23297,903583487,29761.1%
2025-07-22267,987172446,48960.0%
2025-07-21223,626380406,72955.0%
2025-07-18241,218108471,58951.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy